26.11.2012 Views

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Useful sources of these data would be approved product in<strong>for</strong>mation documents<br />

from major regulatory countries, or proposed product in<strong>for</strong>mation documents<br />

stating that these are not yet approved. Summaries of submissions to, or<br />

evaluations from, major regulatory agencies relating to the above are useful, as well<br />

as market research data showing the percentage use <strong>for</strong> the main indications.<br />

B. Requests <strong>for</strong> changes to <strong>ATC</strong> <strong>classification</strong>s<br />

1. Procedures <strong>and</strong> timing<br />

A change in the <strong>ATC</strong> <strong>classification</strong> should be proposed <strong>and</strong> explained in writing<br />

<strong>and</strong> addressed to the WHO Collaborating Centre <strong>for</strong> Drug Statistics Methodology.<br />

Any user may in principle propose changes to <strong>ATC</strong> <strong>classification</strong>s. There is no<br />

application <strong>for</strong>m <strong>for</strong> <strong>ATC</strong> alterations. All proposals <strong>for</strong> changes will be discussed<br />

in the WHO International Working Group <strong>for</strong> Drug Statistics Methodology.<br />

The steps in the evaluation procedure <strong>for</strong> changes to <strong>ATC</strong> <strong>classification</strong>s are as<br />

follows:<br />

- The Centre will confirm receipt of the proposal <strong>for</strong> a change <strong>and</strong> give in<strong>for</strong>mation<br />

about the time schedule <strong>for</strong> discussion at the Working Group meeting.<br />

- After approval of the minutes of the Working Group meeting, the decision from<br />

the meeting concerning the proposed change is distributed from the Centre to<br />

those requesting the change (the applicant). Independent of whether it has been<br />

decided to change or not to change, a deadline will be allowed <strong>for</strong> the applicant to<br />

comment or object to this decision.<br />

- If it is decided to make a change, notification of this change is published at our<br />

website www.whocc.no <strong>and</strong> in the next issue of the WHO Drug In<strong>for</strong>mation. A<br />

deadline is then allowed <strong>for</strong> any interested part to comment or object to the<br />

change.<br />

- If objections, justified on submitted evidence, are received, the <strong>ATC</strong> alteration<br />

will be discussed again at the following meeting of the Working Group, <strong>and</strong> a<br />

final decision will then be taken.<br />

- If no objections are received, the altered <strong>ATC</strong> <strong>classification</strong> will be implemented<br />

in the next issue of the <strong>ATC</strong> <strong>classification</strong> index.<br />

41

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!